Former NHL Player Kelly Chase Shares an Update on His AML Treatment
Kelly Chase’s AML Treatment Update
Former NHL enforcer Kelly Chase was diagnosed with acute myeloid leukemia (AML) in November 2023.
About a year later, on November 8th, 2024, Chase shared the following update about his AML treatment on social media platform X (formerly Twitter):
“I hesitated to say anything, but so many people are sending me notes, so here goes. Yes, I have a Round 2 with this punk called leukemia. With the support of these amazing doctors at the Siteman Center and all my friends’ prayers and support, we are hoping for a similar outcome as Round 1. I am ready to fight again and have a brother with a 100% bone marrow match. I truly am grateful for everyone reaching out. I got this.”
Having a 100% match for a bone marrow transplant, also called a stem cell transplant, can help increase the chances of treatment success.
Click the button below to learn more about stem cell transplants, as taught by AML experts at HealthTree University.
Learn About Stem Cell Transplants for AML
Chase’s NHL Legacy
Kelly Chase had a notable NHL career spanning from 1989 to 2000, during which he played for the St. Louis Blues, Hartford Whalers, and Toronto Maple Leafs.
Throughout his 458 NHL games, Chase scored 53 points, including 17 goals. Due to his tough playing style, he is particularly renowned for accumulating impressive 2017 penalty minutes.
During 27 playoff appearances, he contributed two points, one of which was a goal, alongside 100 penalty minutes.
While Chase never won a Stanley Cup, he was honored with the King Clancy Memorial Trophy in 1998, which recognized his community involvement and leadership both on and off the ice.
Summary
Former NHL player Kelly Chase's experience with acute myeloid leukemia underscores the profound challenges and hopes that come with this cancer. His access to a perfect bone marrow match from his brother highlights the critical role of familial and medical support in treating AML. We wish Chase and his family the best during this difficult time.
Share Your AML Story
Do you have insights you would like to share with others in the AML community? We invite you to email aml@healthtree.org to share your story.
Source:
Kelly Chase’s AML Treatment Update
Former NHL enforcer Kelly Chase was diagnosed with acute myeloid leukemia (AML) in November 2023.
About a year later, on November 8th, 2024, Chase shared the following update about his AML treatment on social media platform X (formerly Twitter):
“I hesitated to say anything, but so many people are sending me notes, so here goes. Yes, I have a Round 2 with this punk called leukemia. With the support of these amazing doctors at the Siteman Center and all my friends’ prayers and support, we are hoping for a similar outcome as Round 1. I am ready to fight again and have a brother with a 100% bone marrow match. I truly am grateful for everyone reaching out. I got this.”
Having a 100% match for a bone marrow transplant, also called a stem cell transplant, can help increase the chances of treatment success.
Click the button below to learn more about stem cell transplants, as taught by AML experts at HealthTree University.
Learn About Stem Cell Transplants for AML
Chase’s NHL Legacy
Kelly Chase had a notable NHL career spanning from 1989 to 2000, during which he played for the St. Louis Blues, Hartford Whalers, and Toronto Maple Leafs.
Throughout his 458 NHL games, Chase scored 53 points, including 17 goals. Due to his tough playing style, he is particularly renowned for accumulating impressive 2017 penalty minutes.
During 27 playoff appearances, he contributed two points, one of which was a goal, alongside 100 penalty minutes.
While Chase never won a Stanley Cup, he was honored with the King Clancy Memorial Trophy in 1998, which recognized his community involvement and leadership both on and off the ice.
Summary
Former NHL player Kelly Chase's experience with acute myeloid leukemia underscores the profound challenges and hopes that come with this cancer. His access to a perfect bone marrow match from his brother highlights the critical role of familial and medical support in treating AML. We wish Chase and his family the best during this difficult time.
Share Your AML Story
Do you have insights you would like to share with others in the AML community? We invite you to email aml@healthtree.org to share your story.
Source:
about the author
Megan Heaps
Megan joined HealthTree in 2022. She enjoys helping patients and their care partners understand the various aspects of the cancer. This understanding enables them to better advocate for themselves and improve their treatment outcomes.
More on Patient Stories
Trending Articles
Get the latest thought leadership on your Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.